100+ Free Arab Board Clinical Pathology Part 1 Practice Questions

Prepare for the Arab Board Clinical Pathology Part 1 Written Examination (ABHS) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Arab Board Specialty Certification Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Sample Arab Board Clinical Pathology Part 1 Practice Questions

Try these sample questions to test your Arab Board Clinical Pathology Part 1 exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 35-year-old man is brought to the emergency department unconscious. Arterial blood gas shows pH 7.12, pCO2 28 mmHg, HCO3- 9 mmol/L, Na+ 140 mmol/L, K+ 5.1 mmol/L, and Cl- 102 mmol/L. Measured serum osmolality is 325 mOsm/kg, blood glucose is 90 mg/dL (5.0 mmol/L), and blood urea nitrogen is 14 mg/dL (5.0 mmol/L). Urinalysis demonstrates envelope-shaped calcium oxalate crystals. What is the calculated osmolar gap and the most likely etiology?

A.Osmolar gap 32 mOsm/kg; Ethylene glycol ingestion

B.Osmolar gap 12 mOsm/kg; Diabetic ketoacidosis

C.Osmolar gap 5 mOsm/kg; Salicylate toxicity

D.Osmolar gap 32 mOsm/kg; Methanol ingestion

Explanation: Calculated osmolality = 2[Na+] + [Glucose mg/dL]/18 + [BUN mg/dL]/2.8 = 2(140) + 5 + 5 = 290 mOsm/kg (or 2[Na+] + Glucose mmol/L + Urea mmol/L = 280 + 5 + 5 = 290 mOsm/kg). The osmolar gap is measured (325) minus calculated (290) = 35 mOsm/kg (elevated > 10 mOsm/kg). The presence of severe high anion gap metabolic acidosis (anion gap = 140 - (102 + 9) = 29) combined with an elevated osmolar gap and calcium oxalate crystals is pathognomonic for ethylene glycol intoxication.

2A 68-year-old woman with chronic kidney disease (stage 4) presents with acute chest discomfort. Initial high-sensitivity cardiac troponin T (hs-cTnT) is 38 ng/L (upper reference limit: 14 ng/L). Which laboratory finding best distinguishes an acute non-ST elevation myocardial infarction (NSTEMI) from chronic baseline elevation in this patient?

A.Elevated baseline serum creatinine

B.A significant rise and/or fall in hs-cTnT on serial testing at 1 to 3 hours

C.A concurrent elevation in serum total creatine kinase (CK)

D.A single troponin value greater than the 99th percentile URL

Explanation: Patients with advanced chronic kidney disease frequently have chronically elevated baseline high-sensitivity cardiac troponin concentrations due to reduced renal clearance and subclinical myocardial remodeling. According to universal definitions of myocardial infarction, establishing acute myocardial infarction requires demonstrating dynamic serial kinetics—a significant rise and/or fall (delta) of hs-cTn on serial sampling at 1 to 3 hours with at least one value above the 99th percentile.

3A routine serum chemistry panel on an asymptomatic 58-year-old man with essential thrombocythemia reveals a serum potassium of 6.6 mmol/L (reference: 3.5-5.0 mmol/L). A simultaneous ECG shows normal sinus rhythm with no peaked T waves or PR prolongation. His platelet count is 980 x 10^9/L. What is the most appropriate laboratory action to establish the true circulating potassium concentration?

A.Repeat the measurement using heparinized plasma maintained at room temperature

B.Repeat the measurement on serum after 4 hours of clot retraction at 4°C

C.Immediately administer intravenous calcium gluconate and insulin-dextrose

D.Perform arterial blood gas analysis using an EDTA tube

Explanation: This patient has pseudohyperkalemia caused by severe thrombocytosis. During in vitro blood clotting in serum collection tubes, massive degranulation of platelets releases high concentrations of intracellular potassium into the serum, resulting in artifactual hyperkalemia. Measuring potassium on heparinized plasma (which prevents in vitro clotting and platelet lysis) maintained at room temperature establishes the accurate in vivo potassium level.

4A 24-year-old woman with type 1 diabetes presents with severe nausea, persistent vomiting, and abdominal pain. Laboratory results are: Na+ 136 mmol/L, K+ 4.8 mmol/L, Cl- 88 mmol/L, HCO3- 16 mmol/L, and arterial blood pH 7.32. Her calculated anion gap is 32 mmol/L. What does calculation of the delta ratio (delta AG / delta HCO3-) indicate regarding her acid-base status?

A.Pure high anion gap metabolic acidosis without any secondary metabolic disorder

B.Mixed high anion gap metabolic acidosis and normal anion gap metabolic acidosis

C.Mixed high anion gap metabolic acidosis and concurrent metabolic alkalosis

D.Pure respiratory acidosis with appropriate renal compensation

Explanation: Normal anion gap is approximately 12 mmol/L and normal HCO3- is 24 mmol/L. Delta AG = measured AG (32) - normal AG (12) = 20 mmol/L. Delta HCO3- = normal HCO3- (24) - measured HCO3- (16) = 8 mmol/L. The delta ratio is Delta AG / Delta HCO3- = 20 / 8 = 2.5. A delta ratio greater than 2.0 indicates that the increase in anion gap is disproportionately greater than the reduction in bicarbonate, proving the presence of a coexisting metabolic alkalosis (caused by loss of gastric hydrochloric acid from persistent vomiting).

5A 45-year-old man with poorly controlled type 2 diabetes and chronic autoimmune hemolytic anemia (hemoglobin 8.8 g/dL, reticulocyte count 8.2%) has home capillary glucose readings consistently averaging 220 mg/dL (12.2 mmol/L). However, his laboratory HbA1c is reported as 5.2% (reference: <5.7%). What is the most appropriate test to monitor his glycemic control?

A.Serum fructosamine assay

B.Oral glucose tolerance test (OGTT)

C.Urine microalbumin-to-creatinine ratio

D.Fasting plasma C-peptide measurement

Explanation: HbA1c reflects average blood glucose over the 120-day lifespan of circulating erythrocytes. In conditions with accelerated red blood cell turnover or hemolysis (such as autoimmune hemolytic anemia), RBC lifespan is markedly shortened, leading to falsely low HbA1c values. Serum fructosamine (or glycated albumin) measures non-enzymatic glycation of serum proteins (chiefly albumin) over a 2- to 3-week window, completely independent of erythrocyte survival.

6A fasting lipid profile on a 52-year-old man with metabolic syndrome reveals: Total Cholesterol 260 mg/dL, HDL-C 35 mg/dL, and Triglycerides 580 mg/dL. Why is the standard Friedewald formula unreliable for calculating LDL cholesterol in this specimen?

A.The formula is invalid when triglycerides exceed 400 mg/dL (4.52 mmol/L)

B.The formula requires direct measurement of apolipoprotein B-100

C.The formula is valid only in pediatric patients under 18 years of age

D.The formula cannot be applied when HDL-C is below 40 mg/dL

Explanation: The Friedewald equation estimates LDL-C as [Total Cholesterol] - [HDL-C] - [Triglycerides/5] (in mg/dL). It assumes a constant 5:1 ratio of triglycerides to cholesterol in VLDL particles. When serum triglycerides exceed 400 mg/dL (4.52 mmol/L) or in dysbetalipoproteinemia (Type III hyperlipidemia), the presence of chylomicrons and triglyceride-rich remnant lipoproteins violates this assumption, causing severe underestimation of LDL-C. Direct homogenous LDL-C assay or ultracentrifugation is required.

7A 23-year-old medical student develops mild scleral icterus during final examination week while fasting. Laboratory evaluation shows: Total Bilirubin 3.2 mg/dL, Direct (conjugated) Bilirubin 0.3 mg/dL, AST 22 U/L, ALT 24 U/L, Alkaline Phosphatase 65 U/L, Hemoglobin 14.8 g/dL, and Reticulocyte count 0.8%. What is the underlying molecular defect?

A.Mutation in the ABCC2 gene encoding the canalicular MRP2 transporter

B.Reduced activity of hepatic UDP-glucuronosyltransferase (UGT1A1) due to a promoter mutation

C.Mutations in SLCO1B1 and SLCO1B3 causing defective organic anion uptake

D.Complete absence of UGT1A1 catalytic activity causing severe kernicterus

Explanation: This patient exhibits classic Gilbert syndrome, characterized by benign, intermittent unconjugated hyperbilirubinemia triggered by fasting, stress, or illness, with entirely normal liver transaminases and no evidence of hemolysis. Gilbert syndrome is most commonly caused by a homozygous TA insertion in the TATA box promoter region of the UGT1A1 gene (A(TA)7TAA instead of A(TA)6TAA, designated UGT1A1*28), resulting in approximately 30% of normal hepatic bilirubin glucuronidation activity.

8A 48-year-old woman with refractory hypertension and unprovoked hypokalemia (K+ 3.0 mmol/L) is screened for primary aldosteronism. She is currently taking spironolactone. Why must mineralocorticoid receptor antagonists (MRAs) be discontinued for at least 4 to 6 weeks prior to measuring the Aldosterone-to-Renin Ratio (ARR)?

A.MRAs directly inhibit the enzymatic synthesis of cortisol in the adrenal cortex

B.MRAs block aldosterone receptors, leading to compensatory elevation of plasma renin activity and false-negative ARR

C.MRAs cross-react in immunoassays, causing falsely elevated plasma renin measurements

D.MRAs induce severe hepatic clearance of aldosterone, rendering plasma aldosterone undetectable

Explanation: Mineralocorticoid receptor antagonists such as spironolactone and eplerenone antagonize renal aldosterone receptors, promoting natriuresis, reducing intravascular volume, and thereby markedly stimulating renal renin release. Elevated plasma renin activity (PRA) lowers the Aldosterone-to-Renin Ratio (ARR = PAC / PRA), frequently yielding a false-negative screening result. Guidelines mandate discontinuing MRAs for 4 to 6 weeks prior to ARR testing.

9A 36-year-old woman presents with persistent fatigue, orthostatic dizziness, nausea, and cutaneous hyperpigmentation. A high-dose short Synacthen (cosyntropin 250 mcg IV) stimulation test is performed. Baseline cortisol is 4.2 mcg/dL (116 nmol/L), 30-minute cortisol is 7.1 mcg/dL (196 nmol/L), and 60-minute cortisol is 8.0 mcg/dL (220 nmol/L). Baseline plasma ACTH is 380 pg/mL (reference: 10-60 pg/mL). What is the correct interpretation?

A.Normal adrenocortical function

B.Primary adrenal insufficiency (Addison disease)

C.Secondary adrenal insufficiency due to pituitary dysfunction

D.Cushing disease with adrenal autonomy

Explanation: A normal response to the short Synacthen stimulation test is defined as a peak serum cortisol >= 18 mcg/dL (approx. 500 nmol/L) at 30 or 60 minutes post-cosyntropin injection. Her peak cortisol of 8.0 mcg/dL confirms adrenal insufficiency. The markedly elevated baseline ACTH (> 2-fold upper reference limit) along with cutaneous hyperpigmentation localizes the defect to the adrenal cortex (Primary Adrenal Insufficiency / Addison disease) due to loss of negative feedback inhibition.

10A serum protein electrophoresis (SPEP) densitometric scan from a hospitalized patient with a severe bacterial pneumonia demonstrates a marked decrease in the albumin band accompanied by prominent, symmetric increases in both the alpha-1 and alpha-2 globulin fractions. What is this electrophoretic pattern characteristic of?

A.Monoclonal gammopathy of undetermined significance (MGUS)

B.Nephrotic syndrome

C.Acute-phase response (systemic inflammation)

D.Alpha-1-antitrypsin deficiency

Explanation: During an acute-phase inflammatory response, hepatic synthesis of negative acute-phase reactants (chiefly albumin and transferrin) decreases, while synthesis of positive acute-phase reactants increases markedly. The alpha-1 fraction rises due to elevated alpha-1-antitrypsin and alpha-1-acid glycoprotein, and the alpha-2 fraction rises due to elevated haptoglobin and alpha-2-macroglobulin, producing the classic acute inflammation electrophoretic profile.

About the Arab Board Clinical Pathology Part 1 Exam

The Arab Board Clinical Pathology Part 1 examination is the written qualifying assessment in the Arab Board of Health Specializations laboratory medicine residency programme. The exam assesses foundational knowledge and diagnostic problem-solving across clinical biochemistry, hematology, coagulation, transfusion medicine, microbiology, virology, mycology, parasitology, immunology, molecular pathology, and laboratory quality management.

Assessment

A single written examination of single-best-answer multiple-choice questions in clinical vignette and laboratory interpretation format.

Time Limit

Approximately 2.5 to 3 hours

Passing Score

Approximately 60%, subject to standard-setting procedures established by the ABHS Scientific Council of Pathology.

Exam Fee

Set by the Arab Board of Health Specializations and member state national councils; verify current rates with your local training centre. (Arab Board of Health Specializations (ABHS))

Arab Board Clinical Pathology Part 1 Exam Content Outline

18%

Clinical Biochemistry

Acid-base balance, electrolytes, renal and hepatic profiles, cardiac biomarkers, endocrine dynamic tests, tumor markers, and therapeutic drug monitoring.

16%

Hematology

Erythrocyte disorders, hemoglobinopathies, automated analyzer principles, benign leukocyte disorders, acute/chronic leukemias, and myelodysplasia.

12%

Coagulation and Hemostasis

Primary and secondary hemostatic disorders, platelet aggregometry, mixing study algorithms, thrombophilia panels, DIC, TTP, and anticoagulant assays.

12%

Blood Transfusion and Immunohematology

ABO and Rh typing, antibody screening and panels, pre-transfusion testing, acute and delayed transfusion reactions, HDFN, and component management.

14%

Clinical Microbiology (Bacteriology)

Bacterial identification algorithms, selective media, anaerobes, mycobacterial diagnostics, antimicrobial susceptibility testing, and resistance mechanisms.

12%

Virology, Mycology and Parasitology

Viral hepatitis serology, HIV diagnostic algorithms, opportunistic mycoses, fungal biomarkers, malaria diagnostics, and diagnostic parasitology.

Clinical Immunology and Serology

Autoantibody patterns, complement cascades, primary immunodeficiencies, flow cytometric immunophenotyping, and immunogenetics.

Molecular Pathology and Laboratory Quality Management

PCR and molecular diagnostics, NGS quality metrics, Westgard rules, Levey-Jennings interpretation, pre-analytical error mitigation, and test validation.

How to Pass the Arab Board Clinical Pathology Part 1 Exam

What You Need to Know

Passing score: Approximately 60%, subject to standard-setting procedures established by the ABHS Scientific Council of Pathology.
Assessment: A single written examination of single-best-answer multiple-choice questions in clinical vignette and laboratory interpretation format.
Time limit: Approximately 2.5 to 3 hours
Exam fee: Set by the Arab Board of Health Specializations and member state national councils; verify current rates with your local training centre.

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Arab Board Clinical Pathology Part 1 Study Tips from Top Performers

1Master diagnostic algorithms for laboratory anomalies, including mixing study workflows, acid-base delta-delta calculations, viral hepatitis serology panels, and transfusion reaction workups.

2Focus on automated analyzer principles, quality control rules (Westgard 1-3s, 2-2s, R-4s), and pre-analytical interference mechanisms (hemolysis, icterus, lipemia) which frequently appear in written questions.

3Integrate morphology and clinical data: practice correlating peripheral blood films, bone marrow findings, Gram stains, and fungal wet mounts with clinical vignettes and automated analyzer flags.

Frequently Asked Questions

What is the format of the Arab Board Clinical Pathology Part 1 exam?

The exam is a single written paper consisting of 100 single-best-answer multiple-choice questions (MCQs) in clinical vignette and laboratory data interpretation formats, completed within 2.5 to 3 hours.

What is the passing standard for the ABHS Clinical Pathology Part 1 exam?

The Arab Board Scientific Council establishes passing thresholds through standard-setting procedures. A score of approximately 60% is standard across most Arab Board Part 1 examinations.

What major laboratory disciplines are tested on this examination?

The examination tests eight core domains: clinical biochemistry, hematology, coagulation, blood transfusion/immunohematology, clinical microbiology, virology/mycology/parasitology, clinical immunology, and molecular pathology with laboratory quality management.

Are these practice questions licensed from the Arab Board?

No. These are high-yield original practice questions created by medical educators to reflect the official ABHS curriculum, question style, and cognitive level for study and self-assessment purposes.

100+ Free Arab Board Clinical Pathology Part 1 Practice Questions

Explore More Arab Board Specialty Certification Exams

Arab Board Pediatrics Part 1 Written Exam (ABHS)

Arab Board Anatomic Pathology Part 1 Written Exam (ABHS)

Arab Board Anesthesia and Intensive Care Final Clinical and Oral Exam (ABHS)

Arab Board Anesthesia and Intensive Care Final Written Exam (ABHS)

Arab Board Anesthesia Part 1 Written Exam (ABHS)

Arab Board Community Medicine Final Written Exam (ABHS)